Autologous microfragmented adipose tissue treatment of knee osteoarthritis demonstrates effectiveness in 68% of patients at 4-year follow-up.
Adipose tissue-derived mesenchymal stem cells
Intra-articular injection
Knee osteoarthritis
Medium term follow-up
Journal
Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
received:
21
06
2023
accepted:
11
11
2023
medline:
12
1
2024
pubmed:
12
1
2024
entrez:
11
1
2024
Statut:
aheadofprint
Résumé
Adipose tissue-derived stem cells are an interesting therapeutic option for early knee osteoarthritis (OA) treatment due to their high plasticity, easiness of harvesting and rapidity of administration. The aim of this study was to evaluate the medium-term effectiveness and safety of Microfragmented Autologous Fat Tissue (MFAT) injection treatment at 4-year follow-up and to investigate potential correlations among patients' pre-treatment clinical condition and clinical outcomes to identify possible predicting factors for procedure success or failure. This is a prospective trial enrolling 46 patients with diagnosis of symptomatic knee OA and failure of previous conservative measures who underwent diagnostic arthroscopy and single autologous MFAT injection between June 2017 and July 2018. Patients were assessed with repeated clinical scoring systems at baseline, 6 months, 1 and 4 years after surgery. The evaluation included demographic characteristics, arthroscopic findings, and stem cell number from injected tissue. No major complications were reported during follow-up period and there was a significant increase of Lysholm knee score from baseline value of 61.7 ± 13.8 to 79.5 ± 16.9 at 4 years (p < 0.001). The WOMAC score increased from a baseline value of 66.5 ± 14.7 to 82.8 ± 15.7 at 4 years (p < 0.001) and there was a significant decrease of VAS pain score from baseline value of 6.3 ± 1.5 to 3.5 ± 2.6 at 4-year follow-up (p < 0.001). ROM improved significantly from 118.4 ± 2.6 to 122.5 ± 2.5 at 12 months (p < 0.001), but did not improve at 4 years (p > 0.05). 15 patients (32.6%) were considered treatment failures, because they required secondary surgery, further injection therapy or experienced symptoms persistence. Patient with synovitis had 75% failure rate, although synovitis did not result as a statistically significant factor influencing clinical outcome up to 4-year follow-up (p = 0.058). Age, cartilage defects severity, BMI, concomitant procedures, and stem cell number from injected MFAT did not show any significant correlation with the results. MFAT intra-articular injection is a safe procedure with positive improvements up to 4-year follow-up in patients with early knee OA. These findings suggest MFAT could be a minimally invasive treatment of early knee OA with durable benefits at mid-term evaluation. IRB number ID-3522.
Sections du résumé
BACKGROUND
BACKGROUND
Adipose tissue-derived stem cells are an interesting therapeutic option for early knee osteoarthritis (OA) treatment due to their high plasticity, easiness of harvesting and rapidity of administration. The aim of this study was to evaluate the medium-term effectiveness and safety of Microfragmented Autologous Fat Tissue (MFAT) injection treatment at 4-year follow-up and to investigate potential correlations among patients' pre-treatment clinical condition and clinical outcomes to identify possible predicting factors for procedure success or failure.
PATIENTS AND METHODS
METHODS
This is a prospective trial enrolling 46 patients with diagnosis of symptomatic knee OA and failure of previous conservative measures who underwent diagnostic arthroscopy and single autologous MFAT injection between June 2017 and July 2018. Patients were assessed with repeated clinical scoring systems at baseline, 6 months, 1 and 4 years after surgery. The evaluation included demographic characteristics, arthroscopic findings, and stem cell number from injected tissue.
RESULTS
RESULTS
No major complications were reported during follow-up period and there was a significant increase of Lysholm knee score from baseline value of 61.7 ± 13.8 to 79.5 ± 16.9 at 4 years (p < 0.001). The WOMAC score increased from a baseline value of 66.5 ± 14.7 to 82.8 ± 15.7 at 4 years (p < 0.001) and there was a significant decrease of VAS pain score from baseline value of 6.3 ± 1.5 to 3.5 ± 2.6 at 4-year follow-up (p < 0.001). ROM improved significantly from 118.4 ± 2.6 to 122.5 ± 2.5 at 12 months (p < 0.001), but did not improve at 4 years (p > 0.05). 15 patients (32.6%) were considered treatment failures, because they required secondary surgery, further injection therapy or experienced symptoms persistence. Patient with synovitis had 75% failure rate, although synovitis did not result as a statistically significant factor influencing clinical outcome up to 4-year follow-up (p = 0.058). Age, cartilage defects severity, BMI, concomitant procedures, and stem cell number from injected MFAT did not show any significant correlation with the results.
CONCLUSIONS
CONCLUSIONS
MFAT intra-articular injection is a safe procedure with positive improvements up to 4-year follow-up in patients with early knee OA. These findings suggest MFAT could be a minimally invasive treatment of early knee OA with durable benefits at mid-term evaluation.
TRIAL REGISTRATION
BACKGROUND
IRB number ID-3522.
Identifiants
pubmed: 38212589
doi: 10.1007/s00402-023-05143-y
pii: 10.1007/s00402-023-05143-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Johnson VL, Hunter DJ (2014) The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol 28:5–15. https://doi.org/10.1016/j.berh.2014.01.004
doi: 10.1016/j.berh.2014.01.004
pubmed: 24792942
Nguyen U-SDT, Zhang Y, Zhu Y et al (2011) Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data. Ann Intern Med 155:725–732. https://doi.org/10.7326/0003-4819-155-11-201112060-00004
doi: 10.7326/0003-4819-155-11-201112060-00004
pubmed: 22147711
pmcid: 3408027
Palazzo C, Nguyen C, Lefevre-Colau M-M et al (2016) Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med 59:134–138. https://doi.org/10.1016/j.rehab.2016.01.006
doi: 10.1016/j.rehab.2016.01.006
pubmed: 26904959
Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393:1745–1759. https://doi.org/10.1016/S0140-6736(19)30417-9
doi: 10.1016/S0140-6736(19)30417-9
pubmed: 31034380
Alessio-Mazzola M, Lovisolo S, Sonzogni B et al (2021) Clinical outcome and risk factor predictive for failure of autologous PRP injections for low-to-moderate knee osteoarthritis. J Orthop Surg (Hong Kong). https://doi.org/10.1177/23094990211021922
doi: 10.1177/23094990211021922
pubmed: 34180298
Bastos R, Mathias M, Andrade R et al (2020) Intra-articular injection of culture-expanded mesenchymal stem cells with or without addition of platelet-rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: a controlled, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc 28:1989–1999. https://doi.org/10.1007/s00167-019-05732-8
doi: 10.1007/s00167-019-05732-8
pubmed: 31587091
Rodeo SA (2019) Cell therapy in orthopaedics: where are we in 2019? Bone Joint J. https://doi.org/10.1302/0301-620X.101B4.BJJ-2019-0013.R1
doi: 10.1302/0301-620X.101B4.BJJ-2019-0013.R1
pubmed: 31474139
Di Matteo B, Polignano A, Onorato F et al (2021) Knee intraosseous injections: a systematic review of clinical evidence of different treatment alternatives. Cartilage 13:1165S-1177S. https://doi.org/10.1177/1947603520959403
doi: 10.1177/1947603520959403
pubmed: 32959675
Verbus EA, Kenyon JD, Sergeeva O et al (2017) Expression of miR-145-5p during chondrogenesis of mesenchymal stem cells. J Stem Cell Res (Overl Park) 1:1–10
pubmed: 29721552
Dimarino AM, Caplan AI, Bonfield TL (2013) Mesenchymal stem cells in tissue repair. Front Immunol 4:201. https://doi.org/10.3389/fimmu.2013.00201
doi: 10.3389/fimmu.2013.00201
pubmed: 24027567
pmcid: 3761350
Lapuente JP, Dos-Anjos S, Blázquez-Martínez A (2020) Intra-articular infiltration of adipose-derived stromal vascular fraction cells slows the clinical progression of moderate-severe knee osteoarthritis: hypothesis on the regulatory role of intra-articular adipose tissue. J Orthop Surg Res 15:137. https://doi.org/10.1186/s13018-020-01664-z
doi: 10.1186/s13018-020-01664-z
pubmed: 32272946
pmcid: 7144053
Tang Z, Lu Y, Zhang S et al (2021) Chondrocyte secretome enriched microparticles encapsulated with the chondrocyte membrane to facilitate the chondrogenesis of BMSCs and reduce hypertrophy. J Mater Chem B Mater Biol Med 9:9989–10002. https://doi.org/10.1039/d1tb02319e
doi: 10.1039/d1tb02319e
pubmed: 34874033
Thorp H, Kim K, Bou-Ghannam S et al (2021) Enhancing chondrogenic potential via mesenchymal stem cell sheet multilayering. Regenerative Therapy 18:487–496. https://doi.org/10.1016/j.reth.2021.11.004
doi: 10.1016/j.reth.2021.11.004
pubmed: 34926734
pmcid: 8645782
Sohn DH, Sokolove J, Sharpe O et al (2012) Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 14:R7. https://doi.org/10.1186/ar3555
doi: 10.1186/ar3555
pubmed: 22225630
pmcid: 3392793
De Francesco F, Gravina P, Busato A et al (2021) Stem cells in autologous microfragmented adipose tissue: current perspectives in osteoarthritis disease. Int J Mol Sci. https://doi.org/10.3390/ijms221910197
doi: 10.3390/ijms221910197
pubmed: 34948110
pmcid: 8709076
de Girolamo L, Lucarelli E, Alessandri G et al (2013) Mesenchymal stem/stromal cells: a new “‘cells as drugs’” paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des 19:2459–2473. https://doi.org/10.2174/1381612811319130015
doi: 10.2174/1381612811319130015
pubmed: 23278600
pmcid: 3788322
Yano K, Speidel AT, Yamato M (2018) Four Food and Drug Administration draft guidance documents and the REGROW Act: a litmus test for future changes in human cell- and tissue-based products regulatory policy in the United States? J Tissue Eng Regen Med 12:1579–1593. https://doi.org/10.1002/term.2683
doi: 10.1002/term.2683
pubmed: 29702746
pmcid: 6055862
Raposio E, Ciliberti R (2017) Clinical use of adipose-derived stem cells: European legislative issues. Ann Med Surg (Lond) 24:61–64. https://doi.org/10.1016/j.amsu.2017.11.002
doi: 10.1016/j.amsu.2017.11.002
pubmed: 29204274
Di Matteo B, Vandenbulcke F, Vitale ND et al (2019) Minimally manipulated mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review of clinical evidence. Stem Cells Int 2019:1735242. https://doi.org/10.1155/2019/1735242
doi: 10.1155/2019/1735242
pubmed: 31485234
pmcid: 6710724
Borić I, Hudetz D, Rod E et al (2019) A 24-month follow-up study of the effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes (Basel). https://doi.org/10.3390/genes10121051
doi: 10.3390/genes10121051
pubmed: 31861180
Russo A, Screpis D, Di Donato SL et al (2018) Autologous micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis: an update at 3 year follow-up. J EXP ORTOP 5:52. https://doi.org/10.1186/s40634-018-0169-x
doi: 10.1186/s40634-018-0169-x
Ferracini R, Alessio-Mazzola M, Sonzogni B et al (2022) Age and synovitis affect the results of the treatment of knee osteoarthritis with Microfragmented Autologous Fat Tissue. Knee Surg Sports Traumatol Arthrosc. https://doi.org/10.1007/s00167-022-07139-4
doi: 10.1007/s00167-022-07139-4
pubmed: 36087128
pmcid: 10435636
Hong Z, Chen J, Zhang S et al (2019) Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop 43:1123–1134. https://doi.org/10.1007/s00264-018-4099-0
doi: 10.1007/s00264-018-4099-0
pubmed: 30109404
Lee W-S, Kim HJ, Kim K-I et al (2019) Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med 8:504–511. https://doi.org/10.1002/sctm.18-0122
doi: 10.1002/sctm.18-0122
pubmed: 30835956
pmcid: 6525553
Lu L, Dai C, Zhang Z et al (2019) Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial. Stem Cell Res Ther 10:143. https://doi.org/10.1186/s13287-019-1248-3
doi: 10.1186/s13287-019-1248-3
pubmed: 31113476
pmcid: 6528322
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502. https://doi.org/10.1136/ard.16.4.494
doi: 10.1136/ard.16.4.494
pubmed: 13498604
pmcid: 1006995
Mayhew D, Mendonca V, Murthy BVS (2019) A review of ASA physical status - historical perspectives and modern developments. Anaesthesia 74:373–379. https://doi.org/10.1111/anae.14569
doi: 10.1111/anae.14569
pubmed: 30648259
van den Borne MPJ, Raijmakers NJH, Vanlauwe J et al (2007) International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in Autologous Chondrocyte Implantation (ACI) and microfracture. Osteoarthr Cartil 15:1397–1402. https://doi.org/10.1016/j.joca.2007.05.005
doi: 10.1016/j.joca.2007.05.005
Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
pubmed: 3068365
Lysholm J, Gillquist J (1982) Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med 10:150–154. https://doi.org/10.1177/036354658201000306
doi: 10.1177/036354658201000306
pubmed: 6896798
Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16:87–101. https://doi.org/10.1016/0304-3959(83)90088-X
doi: 10.1016/0304-3959(83)90088-X
pubmed: 6602967
Kvien TK, Heiberg T, Hagen KB (2007) Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? Ann Rheum Dis 66(Suppl 3):iii40–iii41. https://doi.org/10.1136/ard.2007.079798
doi: 10.1136/ard.2007.079798
pubmed: 17934093
pmcid: 2095292
Roato I, Belisario DC, Compagno M et al (2019) Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations. Int Orthop 43:15–23. https://doi.org/10.1007/s00264-018-4192-4
doi: 10.1007/s00264-018-4192-4
pubmed: 30311059
Kurosaka M, Ohno O, Hirohata K (1991) Arthroscopic evaluation of synovitis in the knee joints. Arthroscopy 7:162–170. https://doi.org/10.1016/0749-8063(91)90104-6
doi: 10.1016/0749-8063(91)90104-6
pubmed: 2069628
Gadelkarim M, Abd Elmegeed A, Allam AH et al (2022) Safety and efficacy of adipose-derived mesenchymal stem cells for knee osteoarthritis: A systematic review and m-analysis. Joint Bone Spine 89:105404. https://doi.org/10.1016/j.jbspin.2022.105404
doi: 10.1016/j.jbspin.2022.105404
pubmed: 35534001
Kim K-I, Lee W-S, Kim J-H et al (2022) Safety and efficacy of the intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritic knee: a 5-year follow-up study. Stem Cells Transl Med 11:586–596. https://doi.org/10.1093/stcltm/szac024
doi: 10.1093/stcltm/szac024
pubmed: 35567774
pmcid: 9216498
Peterfy CG, Guermazi A, Zaim S et al (2004) Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthr Cartil 12:177–190. https://doi.org/10.1016/j.joca.2003.11.003
doi: 10.1016/j.joca.2003.11.003
Mazini L, Rochette L, Amine M, Malka G (2019) Regenerative capacity of adipose derived stem cells (ADSCs). comparison with mesenchymal stem cells (MSCs). Int J Mol Sci. https://doi.org/10.3390/ijms20102523
doi: 10.3390/ijms20102523
pubmed: 31121953
pmcid: 6566837
Shanmugasundaram S, Vaish A, Chavada V et al (2021) Assessment of safety and efficacy of intra-articular injection of stromal vascular fraction for the treatment of knee osteoarthritis-a systematic review. Int Orthop 45:615–625. https://doi.org/10.1007/s00264-020-04926-x
doi: 10.1007/s00264-020-04926-x
pubmed: 33432400
Meng HY-H, Lu V, Khan W (2021) Adipose tissue-derived mesenchymal stem cells as a potential restorative treatment for cartilage defects: a PRISMA review and meta-analysis. Pharmaceuticals (Basel). https://doi.org/10.3390/ph14121280
doi: 10.3390/ph14121280
pubmed: 34959680
pmcid: 7996087
Agarwal N, Mak C, Bojanic C et al (2021) Meta-analysis of adipose tissue derived cell-based therapy for the treatment of knee osteoarthritis. Cells. https://doi.org/10.3390/cells10061365
doi: 10.3390/cells10061365
pubmed: 34831363
pmcid: 8624113
Ranmuthu CDS, Ranmuthu CKI, Khan WS (2018) Evaluating the current literature on treatments containing adipose-derived stem cells for osteoarthritis: a progress update. Curr Rheumatol Rep 20:67. https://doi.org/10.1007/s11926-018-0776-7
doi: 10.1007/s11926-018-0776-7
pubmed: 30203213
Maheshwer B, Polce EM, Paul K et al (2021) Regenerative potential of mesenchymal stem cells for the treatment of knee osteoarthritis and chondral defects: a systematic review and meta-analysis. Arthroscopy 37:362–378. https://doi.org/10.1016/j.arthro.2020.05.037
doi: 10.1016/j.arthro.2020.05.037
pubmed: 32497658
Koh Y-G, Choi Y-J, Kwon S-K et al (2015) Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 23:1308–1316. https://doi.org/10.1007/s00167-013-2807-2
doi: 10.1007/s00167-013-2807-2
pubmed: 24326779
Bąkowski P, Kaszyński J, Baka C et al (2021) Patients with stage II of the knee osteoarthritis most likely benefit from the intra-articular injections of autologous adipose tissue-from 2 years of follow-up studies. Arch Orthop Trauma Surg. https://doi.org/10.1007/s00402-021-03979-w
doi: 10.1007/s00402-021-03979-w
pubmed: 34117558
pmcid: 9886583
Migliorini F, Rath B, Colarossi G et al (2020) Improved outcomes after mesenchymal stem cells injections for knee osteoarthritis: results at 12-months follow-up: a systematic review of the literature. Arch Orthop Trauma Surg 140:853–868. https://doi.org/10.1007/s00402-019-03267-8
doi: 10.1007/s00402-019-03267-8
pubmed: 31456015
Beaufils P, Becker R, Kopf S et al (2017) Surgical management of degenerative meniscus lesions: the 2016 ESSKA meniscus consensus. Knee Surg Sports Traumatol Arthrosc 25:335–346. https://doi.org/10.1007/s00167-016-4407-4
doi: 10.1007/s00167-016-4407-4
pubmed: 28210788
pmcid: 5331096
Vasso M, Corona K, Capasso L et al (2022) Intraarticular injection of microfragmented adipose tissue plus arthroscopy in isolated primary patellofemoral osteoarthritis is clinically effective and not affected by age, BMI, or stage of osteoarthritis. J Orthop Traumatol 23:7. https://doi.org/10.1186/s10195-022-00628-9
doi: 10.1186/s10195-022-00628-9
pubmed: 35122541
pmcid: 8818068
Jo CH, Chai JW, Jeong EC et al (2017) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am J Sports Med 45:2774–2783. https://doi.org/10.1177/0363546517716641
doi: 10.1177/0363546517716641
pubmed: 28746812
Filardo G, Tschon M, Perdisa F et al (2022) Micro-fragmentation is a valid alternative to cell expansion and enzymatic digestion of adipose tissue for the treatment of knee osteoarthritis: a comparative preclinical study. Knee Surg Sports Traumatol Arthrosc 30:773–781. https://doi.org/10.1007/s00167-020-06373-y
doi: 10.1007/s00167-020-06373-y
pubmed: 33464397
von Engelhardt LV, Kraft CN, Pennekamp PH et al (2007) The evaluation of articular cartilage lesions of the knee with a 3-Tesla magnet. Arthroscopy 23:496–502. https://doi.org/10.1016/j.arthro.2006.12.027
doi: 10.1016/j.arthro.2006.12.027